Abstract
Offspring born to pregnant mice with a preeclampsia-like condition induced by overexpression of sFlt-1 develop hypertension later in life. Our objective was to determine the role of maternal vascular endothelial growth factor therapy in preventing this fetal programming of blood pressure (BP) in this animal model of preeclampsia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
